Rigel Pharmaceuticals Welcomes Michael P. Miller to Board of Directors Rigel Pharmaceuticals has appointed Michael P. Miller to its Board of Directors, bringing extensive experience in biotech and pharmaceuticals to the team.

Rigel Pharmaceuticals Welcomes Michael P. Miller to Board of Directors #USA #South_San_Francisco #Rigel_Pharmaceuticals #Biotech_Leadership #Mike_Miller

Averna Therapeutics Appoints Dr. Thomas M. Barnes as New CEO to Drive Genomic Medicine Innovations Averna Therapeutics has appointed Dr. Thomas M. Barnes as CEO, bringing over 25 years of biotech leadership to advance genomic medicine development for diseases.

Averna Therapeutics Appoints Dr. Thomas M. Barnes as New CEO to Drive Genomic Medicine Innovations #USA #Boston #Averna_Therapeutics #Thomas_M._Barnes #Biotech_Leadership